I am excited to have Grant join the Nuvalent board. His experience and insights will be critical as we move towards commercialuzation.
Join us in welcoming Grant Bogle to our board of directors! We welcome his collaboration and insights as we work toward our goal of a first potential approval in 2026 from our pipeline of precisely targeted therapies for patients with cancer. Learn more: https://bit.ly/3ZKAT9J #Biotech #BusinessDevelopment #Oncology
Chief Business Officer
20hCongrats Anna!